| Code | CSB-RA023602MB1HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is a research-grade biosimilar to CNTO-3157, designed for research targeting Toll-like receptor 3 (TLR3). TLR3 is a pattern recognition receptor that detects double-stranded RNA, a molecular signature of viral infection and cellular damage. Upon activation, TLR3 initiates innate immune responses through the TRIF-dependent signaling pathway, leading to production of type I interferons and pro-inflammatory cytokines. TLR3 plays critical roles in antiviral immunity, inflammatory responses, and immune regulation. Dysregulation of TLR3 signaling has been implicated in various pathological conditions including viral infections, autoimmune diseases, inflammatory disorders, and cancer progression.
CNTO-3157 is a human monoclonal antibody that specifically binds to TLR3 and has been investigated for its potential to modulate TLR3-mediated immune responses. This biosimilar antibody provides researchers with a valuable tool for investigating TLR3 biology, studying innate immune mechanisms, exploring TLR3-related disease pathogenesis, and evaluating potential therapeutic interventions targeting this receptor in preclinical models.
There are currently no reviews for this product.